Revolutionizing The Global
Fight Against Cancer
Acuamark Diagnostics develops technology which allows for highly accurate screening of blood to detect cancer markers at the early cancer stages, before the cancer becomes untreatable.
Backed by a highly experienced team of scientific and business professionals, it is our mission to contribute to the global battle against cancer by detecting and attacking cancer through high-precision, early detection.
Highly Accurate Technology
Innovative, Differentiated Technology for
Early Cancer Detection
Our Eagle i5 assays detect cancer markers in multiple dimensions, including mutation, methylation, exosomal miRNA, lncRNA and mRNA, translocations and splice variants.
From there, we are able to quantitatively determine the cancer marker load in a blood sample.
Acuamark Diagnostics develops technology that allows for highly accurate screening of blood to detect cancer markers at the early cancer stages, before cancer becomes untreatable.